
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma
Keywords: شیمیدرمانی نئوادجوانت; Interleukin; CyclinD1; Gastric cancer; Neoadjuvant chemotherapy; Prognosis